(R)-MLN-4760, ≥99.9%

(R)-MLN-4760

(R)-ND-336, ≥99%

(R)-ND-336

(R)-Simurosertib ((R)-TAK-931, 99%

(R)-Simurosertib ((R)-TAK-931

(R)-Trolox, 99%

(R)-Trolox

(R)-VU 6008667, 99%

(R)-VU 6008667

(R)-Zanubrutinib ((R)-BGB-3111), 99%

(R)-Zanubrutinib ((R)-BGB-3111)

(R,S)-Ivosidenib((R,S)-AG-120), 99%

(R,S)-Ivosidenib((R,S)-AG-120)

(Rac)-NMDAR antagonist 1, 99%

(Rac)-NMDAR antagonist 1

(Rac)-PT2399, 99%

(Rac)-PT2399

(RS)-Butyryltimolol, 99%

(RS)-Butyryltimolol

(S)-(+)-MT-45 hydrochloride, 99%

(S)-(+)-MT-45 hydrochloride

(S)-3'-amino Blebbistatin, 99%

(S)-3'-amino Blebbistatin

(S)-3'-hydroxy Blebbistatin, 99%

(S)-3'-hydroxy Blebbistatin

(S)-3-Hydroxyisobutyric acid, 99%

(S)-3-Hydroxyisobutyric acid

(S)-3-羟基正丁酸钠, ≧98%

(S)-(+)-3-Hydroxybutyric acid sodium salt

(S)-4-((S)-2-氨基丙酰胺基)-5-(((S)-3-羧基-1-((羧甲基)氨基)-1-氧代丙烷-2-基)氨基)-5-氧代戊酸, ≥99.9%

4-[(2-Amino-1-hydroxypropylidene)amino]-5-(_{3-carboxy-1-[(carboxymethyl)imino]-1-hydroxypropan-2-yl}imino)-5-hydroxypentanoic acid

(S)-4-氨基-5-己烯酸,

S(+)-γ-Vigabatrin

(S)-Ceralasertib, 99%

(S)-Ceralasertib

(S)-Desoxy-D2PM hydrochloride, 99%

(S)-Desoxy-D2PM hydrochloride ((S)-2-Diphenylmethylpyrrolidine)

(S)-Duloxetine D3 hydrochloride, ≥99%

Duloxetine D3 hydrochloride